Meet the
People Behind Novocardia

Brian is a highly experienced IT leader who brings proficiency in design, development, and administration of technology infrastructure and applications to his role as Vice President, IT & Business Systems at Novocardia. He has held a number of leadership positions in IT across multiple industries, including health care. He most recently served as Director of IT Operations at Seniorlink, where he was responsible for providing strategic guidance on all corporate infrastructure, cloud, security, and service desk services. He earned an MBA from Whittemore School of Business & Economics (now the Peter T. Paul College of Business and Economics) at the University of New Hampshire and an undergraduate degree in Computer Science from Dickinson College.

Ana is Vice President of Contracting and Value Based Partnerships at Novocardia, where she is responsible for leading contract strategies and negotiations with Commercial payers and risk provider groups. Highly focused on fee-for-value contracting, provider performance improvement, and management services operations, Ana has more than 30 years of experience in the health care industry – including payer reimbursement models, government shared saving programs, IPAs, and Medicare Risk Adjustments. Prior to Novocardia, she served in several leadership roles with a multi-specialty group and accountable care organization. Ana received her undergraduate degree in business from Florida International University and is a licensed professional medical coder.

As the Vice President of Central Operations and Integration, Jesse focuses on evolving strategic administrative functions that will support long-term growth and empower clinicians to deliver high-quality patient care and outcomes. She is a dedicated leader with over 30 years of experience helping organizations grow and form successful integrative relationships. Prior to joining Novocardia, Jesse led the Integration Management Office at United Urology Group and served as Lead Marketing Manager at T. Rowe Price, and Training Manager at Discovery Communications. She earned her BA in Psychology from Washington College.

As Vice President of Product for Novocardia, Kate leads development and implementation of new products and programs designed to create value and improve outcomes in cardiovascular care. She has a wealth of experience in value-based care, including developing innovative new programs and products, and strategic partnerships, most recently in various leadership roles at Aledade. Previously, she worked in healthcare operations and consulting at Steward Health Care, Cerberus Operations & Advisory Group and FTI Consulting. Kate received her undergraduate degree in Commerce from University of Virginia, and an MBA from Columbia University.

Dr. Dan Blumenthal brings a unique combination of business leadership skills and medical expertise to his role as Chief Executive Officer. Dr. Blumenthal is a practicing board-certified non-invasive cardiologist and an instructor at Harvard Medical School. He received his MD and MBA degrees from Harvard Medical School and Harvard Business School and trained in internal medicine and cardiology at the Massachusetts General Hospital. Dr. Blumenthal is a past recipient of the American Heart Association’s Laennec Young Clinician Award and an accomplished health services and cardiovascular disease outcomes researcher whose previous work has focused on innovations in payment model design, quality improvement in cardiology, and leadership development. He has published over 50 manuscripts in peer-reviewed journals. Dr. Blumenthal previously was a member of the founding team at Devoted Health, where he held the roles of Associate Chief Medical Officer and Medical Director for the health plan.

Michael R. Jaff, DO is the Chief Medical Officer and Vice-President of clinical affairs, technology and innovation at Boston Scientific Corporation. A former professor of medicine at Harvard Medical School, Dr. Jaff was the President of Newton-Wellesley Hospital from October 2016-December 2019. Prior to that, Dr. Jaff was the inaugural Paul and Phyllis Fireman Endowed Chair of Vascular Medicine and Medical Director of the Fireman Vascular Center at the Massachusetts General Hospital. He is an expert in all aspects of vascular medicine, including peripheral artery disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine. He is the founder of VasCore, the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. VasCore has participated in trial design and independent analysis of vascular laboratory images for over 200 prospective multicenter peripheral vascular device and pharmaceutical trials across 66 countries. Dr. Jaff has published extensively in the field of Vascular Medicine with over 325 peer- reviewed publications and 10 textbooks, is the Past-President of the Society for Vascular Medicine and Biology and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI). In November 2011, Dr. Jaff became an alumnus of Harvard Business School after completing the General Management Program.